Abstract
Polyriboinosinic-polyribocytidylic acid [poly(IC.LC)] was evaluated for its prophylactic and therapeutic efficacies against respiratory influenza A virus infection in mice. Two doses of poly(IC.LC) (1 mg/kg of body weight per dose) administered intranasally within 12 days prior to infection with 10 50% lethal doses of mouse-adapted influenza A/PR/8 virus fully protected the mice against the infection. Determination of virus titers by hemagglutination and plaque assays showed more than a 2-log10 decrease in virus titers in lung homogenates of pretreated mice compared with those in the lungs of the nonpretreated group. Treatment of infected mice with poly(IC.LC) resulted in a modest (40%) survival rate. These results suggest that poly(IC.LC) provides a highly effective prophylaxis against respiratory influenza A virus infection in mice.
Full Text
The Full Text of this article is available as a PDF (178.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baer G. M., Shaddock J. H., Moore S. A., Yager P. A., Baron S. S., Levy H. B. Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine. J Infect Dis. 1977 Aug;136(2):286–291. doi: 10.1093/infdis/136.2.286. [DOI] [PubMed] [Google Scholar]
- Chirigos M. A., Welker R., Schlick E., Saito T., Ruffmann R. Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC. Prog Clin Biol Res. 1984;161:467–479. [PubMed] [Google Scholar]
- Harrington D. G., Hilmas D. E., Elwell M. R., Whitmire R. E., Stephen E. L. Intranasal infection of monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly (I).poly (C). Am J Trop Med Hyg. 1977 Nov;26(6 Pt 1):1191–1198. doi: 10.4269/ajtmh.1977.26.1191. [DOI] [PubMed] [Google Scholar]
- Kende M., Alving C. R., Rill W. L., Swartz G. M., Jr, Canonico P. G. Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice. Antimicrob Agents Chemother. 1985 Jun;27(6):903–907. doi: 10.1128/aac.27.6.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kende M. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice. J Biol Response Mod. 1985 Oct;4(5):503–511. [PubMed] [Google Scholar]
- Levy H. B., Baer G., Baron S., Buckler C. E., Gibbs C. J., Iadarola M. J., London W. T., Rice J. A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis. 1975 Oct;132(4):434–439. doi: 10.1093/infdis/132.4.434. [DOI] [PubMed] [Google Scholar]
- McFarlin D. E., Bever C. T., Salazar A. M., Levy H. B. A preliminary trial of poly(I,C)-LC in multiple sclerosis. J Biol Response Mod. 1985 Oct;4(5):544–548. [PubMed] [Google Scholar]
- Stephen E. L., Hilmas D. E., Levy H. B., Spertzel R. O. Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys. J Infect Dis. 1979 Mar;139(3):267–272. doi: 10.1093/infdis/139.3.267. [DOI] [PubMed] [Google Scholar]
- Stephen E. L., Sammons M. L., Pannier W. L., Baron S., Spertzel R. O., Levy H. B. Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). J Infect Dis. 1977 Jul;136(1):122–126. doi: 10.1093/infdis/136.1.122. [DOI] [PubMed] [Google Scholar]
- Wiltrout R. H., Salup R. R., Twilley T. A., Talmadge J. E. Immunomodulation of natural killer activity by polyribonucleotides. J Biol Response Mod. 1985 Oct;4(5):512–517. [PubMed] [Google Scholar]
- Wong J. P., Stadnyk L. L., Saravolac E. G. Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody. Immunology. 1994 Feb;81(2):280–284. [PMC free article] [PubMed] [Google Scholar]